Drug
Lai
Lai: highest development phase Phase 3, developed by Insmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAI 590 mg NCT02628600 | Phase 3 | NTM Lung Infection Due to MAC |
Latest
No recent events.
Follow Lai on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.